{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:29:29Z","timestamp":1782473369460,"version":"3.54.5"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Exercise is increasingly applied as non-pharmacological intervention in Parkinson\u2019s disease (PD). While evidence suggests beneficial effects, the mechanisms, optimal intensity, and potential risks remain unclear. This study investigated the effects of treadmill exercise on motor and non-motor symptoms, alpha-synuclein pathology, neuroinflammation, and gut microbiota composition in Thy1-aSyn transgenic mice, a model of prodromal PD. Moderate (5\u2009m\/min) or intensive (12.5\u201315\u2009m\/min) treadmill exercise three times a week for one month delayed motor deficits, with improvements in beam-walking performance and gait coordination. Intensive training attenuated anxiety-like behavior and reduced phosphorylated alpha-synuclein accumulation in the substantia nigra, but not in limbic regions, demonstrating region-specific pathology modulation. Despite absent baseline neuroinflammation, intensive exercise increased microglial reactivity in the amygdala and hippocampus. Additionally, exercise increased fecal microbiota diversity across genotypes, with selective enrichment of Lachnospiraceae. These findings suggest that exercise modulates PD-related pathology and motor symptoms, although intensity-dependent limbic microgliosis warrants further investigation.<\/jats:p>","DOI":"10.1038\/s41531-025-01200-y","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T02:34:55Z","timestamp":1763865295000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Depending on intensity, exercise improved or worsened pathology in a model of prodromal Parkinson\u2019s disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Leonie","family":"Baldauf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Feja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milos","family":"Stanojlovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Strowig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Visscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Schaeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hankel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,23]]},"reference":[{"key":"1200_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe, W. et al. Parkinson disease. Nat. Rev. Dis. Prim. 3, 17013 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1200_CR2","doi-asserted-by":"publisher","first-page":"III\/1","DOI":"10.1007\/s00415-002-1301-4","volume":"249","author":"H Braak","year":"2002","unstructured":"Braak, H. et al. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson\u2019s disease (preclinical and clinical stages). J. Neurol. 249, III\/1\u2013III\/5 (2002).","journal-title":"J. Neurol."},{"key":"1200_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101816","volume":"84","author":"A Kulkarni","year":"2023","unstructured":"Kulkarni, A. et al. Proteostasis in Parkinson\u2019s disease: Recent development and possible implication in diagnosis and therapeutics. Ageing Res. Rev. 84, 101816 (2023).","journal-title":"Ageing Res. Rev."},{"key":"1200_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101915","volume":"87","author":"S Rajan","year":"2023","unstructured":"Rajan, S. et al. Understanding the involvement of innate immunity and the Nrf2-NLRP3 axis on mitochondrial health in Parkinson\u2019s disease. Ageing Res. Rev. 87, 101915 (2023).","journal-title":"Ageing Res. Rev."},{"key":"1200_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuron.2024.09.015","volume":"113","author":"JE Palmer","year":"2025","unstructured":"Palmer, J. E. et al. Autophagy, aging, and age-related neurodegeneration. Neuron 113, 29\u201348 (2025).","journal-title":"Neuron"},{"key":"1200_CR6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey, M. G. et al. Inflammation and immune dysfunction in Parkinson disease. Nat. Rev. Immunol. 22, 657\u2013673 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"1200_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris, H. R., Spillantini, M. G., Sue, C. M. & Williams-Gray, C. H. The pathogenesis of Parkinson\u2019s disease. Lancet 403, 293\u2013304 (2024).","journal-title":"Lancet"},{"key":"1200_CR8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00401-021-02349-5","volume":"142","author":"M Hartlage-Rubsamen","year":"2021","unstructured":"Hartlage-Rubsamen, M. et al. A glutaminyl cyclase-catalyzed alpha-synuclein modification identified in human synucleinopathies. Acta Neuropathol. 142, 399\u2013421 (2021).","journal-title":"Acta Neuropathol."},{"key":"1200_CR9","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G. et al. Alpha-synuclein in Lewy bodies. Nature 388, 839\u2013840 (1997).","journal-title":"Nature"},{"key":"1200_CR10","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/mds.24921","volume":"27","author":"K Del Tredici","year":"2012","unstructured":"Del Tredici, K. & Braak, H. Lewy pathology and neurodegeneration in premotor Parkinson\u2019s disease. Mov. Disord. 27, 597\u2013607 (2012).","journal-title":"Mov. Disord."},{"key":"1200_CR11","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3233\/JPD-229002","volume":"12","author":"K McFarthing","year":"2022","unstructured":"McFarthing, K. et al. Parkinson\u2019s disease drug therapies in the clinical trial pipeline: 2022 Update. J. Parkinsons Dis. 12, 1073\u20131082 (2022).","journal-title":"J. Parkinsons Dis."},{"key":"1200_CR12","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/mds.29398","volume":"38","author":"A Schidlitzki","year":"2023","unstructured":"Schidlitzki, A. et al. Double-edged effects of venglustat on behavior and pathology in mice overexpressing alpha-Synuclein. Mov. Disord. 38, 1044\u20131055 (2023).","journal-title":"Mov. Disord."},{"key":"1200_CR13","doi-asserted-by":"crossref","unstructured":"Richter, F. Alpha-synuclein as therapeutic target in Parkinson\u2019s disease. Neuroforum 25 (2019).","DOI":"10.1515\/nf-2018-0029"},{"key":"1200_CR14","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/brain\/awt192","volume":"136","author":"JH Kordower","year":"2013","unstructured":"Kordower, J. H. et al. Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease. Brain 136, 2419\u20132431 (2013).","journal-title":"Brain"},{"key":"1200_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","volume":"17","author":"D Berg","year":"2021","unstructured":"Berg, D. et al. Prodromal Parkinson disease subtypes - key to understanding heterogeneity. Nat. Rev. Neurol. 17, 349\u2013361 (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"1200_CR16","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s00702-022-02509-1","volume":"129","author":"H Reichmann","year":"2022","unstructured":"Reichmann, H. et al. Life style and Parkinson\u2019s disease. J. Neural Transm. 129, 1235\u20131245 (2022).","journal-title":"J. Neural Transm."},{"key":"1200_CR17","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-230428","author":"E Schaeffer","year":"2024","unstructured":"Schaeffer, E., Yilmaz, R., St Louis, E. K. & Noyce, A. J. Ethical considerations for identifying individuals in the prodromal\/early phase of Parkinson\u2019s Disease: A narrative review. J. Parkinsons Dis. https:\/\/doi.org\/10.3233\/JPD-230428 (2024).","journal-title":"J. Parkinsons Dis."},{"key":"1200_CR18","doi-asserted-by":"publisher","first-page":"e859","DOI":"10.1212\/WNL.0000000000013218","volume":"98","author":"K Tsukita","year":"2022","unstructured":"Tsukita, K., Sakamaki-Tsukita, H. & Takahashi, R. Long-term effect of regular physical activity and exercise habits in patients with early Parkinson disease. Neurology 98, e859\u2013e871 (2022).","journal-title":"Neurology"},{"key":"1200_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2025.149540","volume":"1854","author":"D Kumar","year":"2025","unstructured":"Kumar, D. et al. Treadmill exercise mitigates rotenone-induced neuroinflammation and alpha-synuclein level in a mouse model of Parkinson\u2019s disease. Brain Res 1854, 149540 (2025).","journal-title":"Brain Res"},{"key":"1200_CR20","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3233\/JPD-181534","volume":"9","author":"H Gassner","year":"2019","unstructured":"Gassner, H. et al. Perturbation Treadmill Training Improves Clinical Characteristics of Gait and Balance in Parkinson\u2019s Disease. J. Parkinsons Dis. 9, 413\u2013426 (2019).","journal-title":"J. Parkinsons Dis."},{"key":"1200_CR21","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1001\/jamaneurol.2021.3926","volume":"78","author":"SY Yoon","year":"2021","unstructured":"Yoon, S. Y., Suh, J. H., Yang, S. N., Han, K. & Kim, Y. W. Association of physical activity, including amount and maintenance, with all-cause mortality in Parkinson disease. JAMA Neurol. 78, 1446\u20131453 (2021).","journal-title":"JAMA Neurol."},{"key":"1200_CR22","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S1474-4422(19)30285-6","volume":"18","author":"NM van der Kolk","year":"2019","unstructured":"van der Kolk, N. M. et al. Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson\u2019s disease: a double-blind, randomised controlled trial. Lancet Neurol. 18, 998\u20131008 (2019).","journal-title":"Lancet Neurol."},{"key":"1200_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1001\/jamaneurol.2017.3517","volume":"75","author":"M Schenkman","year":"2018","unstructured":"Schenkman, M. et al. Effect of high-intensity treadmill exercise on motor symptoms in patients with De Novo Parkinson disease: A Phase 2 randomized clinical trial. JAMA Neurol. 75, 219\u2013226 (2018).","journal-title":"JAMA Neurol."},{"key":"1200_CR24","doi-asserted-by":"publisher","first-page":"e182421","DOI":"10.1001\/jamanetworkopen.2018.2421","volume":"1","author":"X Fang","year":"2018","unstructured":"Fang, X. et al. Association of levels of physical activity with risk of Parkinson disease: a systematic review and meta-analysis. JAMA Netw. Open 1, e182421 (2018).","journal-title":"JAMA Netw. Open"},{"key":"1200_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/ana.26291","volume":"91","author":"ME Johansson","year":"2022","unstructured":"Johansson, M. E. et al. Aerobic exercise alters brain function and structure in Parkinson\u2019s disease: a randomized controlled trial. Ann. Neurol. 91, 203\u2013216 (2022).","journal-title":"Ann. Neurol."},{"key":"1200_CR26","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1212\/WNL.0b013e318225ab66","volume":"77","author":"JE Ahlskog","year":"2011","unstructured":"Ahlskog, J. E. Does vigorous exercise have a neuroprotective effect in Parkinson disease?. Neurology 77, 288\u2013294 (2011).","journal-title":"Neurology"},{"key":"1200_CR27","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s00213-016-4218-9","volume":"233","author":"MA Calcia","year":"2016","unstructured":"Calcia, M. A. et al. Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness. Psychopharmacology 233, 1637\u20131650 (2016).","journal-title":"Psychopharmacology"},{"key":"1200_CR28","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fncel.2018.00282","volume":"12","author":"C Lecours","year":"2018","unstructured":"Lecours, C. et al. Microglial implication in Parkinson\u2019s disease: loss of beneficial physiological roles or gain of inflammatory functions?. Front Cell Neurosci. 12, 282 (2018).","journal-title":"Front Cell Neurosci."},{"key":"1200_CR29","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.immuni.2019.12.003","volume":"52","author":"C Madore","year":"2020","unstructured":"Madore, C., Yin, Z., Leibowitz, J. & Butovsky, O. Microglia, lifestyle stress, and neurodegeneration. Immunity 52, 222\u2013240 (2020).","journal-title":"Immunity"},{"key":"1200_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ynstr.2016.09.002","volume":"5","author":"M Svensson","year":"2016","unstructured":"Svensson, M. et al. Forced treadmill exercise can induce stress and increase neuronal damage in a mouse model of global cerebral ischemia. Neurobiol. Stress 5, 8\u201318 (2016).","journal-title":"Neurobiol. Stress"},{"key":"1200_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-63045-4","volume":"14","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Aerobic exercise improves motor dysfunction in Parkinson\u2019s model mice via differential regulation of striatal medium spiny neuron. Sci. Rep. 14, 12132 (2024).","journal-title":"Sci. Rep."},{"key":"1200_CR32","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3389\/fneur.2019.01143","volume":"10","author":"E Palasz","year":"2019","unstructured":"Palasz, E. et al. Exercise-induced neuroprotection and recovery of motor function in animal models of Parkinson\u2019s disease. Front Neurol. 10, 1143 (2019).","journal-title":"Front Neurol."},{"key":"1200_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s13311-022-01338-0","volume":"20","author":"F Richter","year":"2023","unstructured":"Richter, F., Stanojlovic, M., Kaufer, C., Gericke, B. & Feja, M. A Mouse Model to Test Novel Therapeutics for Parkinson\u2019s Disease: an Update on the Thy1-aSyn (\u201cline 61\u201d) Mice. Neurotherapeutics 20, 97\u2013116 (2023).","journal-title":"Neurotherapeutics"},{"key":"1200_CR34","doi-asserted-by":"publisher","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","volume":"24","author":"SM Fleming","year":"2004","unstructured":"Fleming, S. M. et al. Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. J. Neurosci. 24, 9434\u20139440 (2004).","journal-title":"J. Neurosci."},{"key":"1200_CR35","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/jnr.22611","volume":"89","author":"HA Lam","year":"2011","unstructured":"Lam, H. A. et al. Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human alpha-synuclein. J. Neurosci. Res. 89, 1091\u20131102 (2011).","journal-title":"J. Neurosci. Res."},{"key":"1200_CR36","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.expneurol.2012.06.025","volume":"237","author":"MB Watson","year":"2012","unstructured":"Watson, M. B. et al. Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein. Exp. Neurol. 237, 318\u2013334 (2012).","journal-title":"Exp. Neurol."},{"key":"1200_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105478","volume":"158","author":"ERS Torres","year":"2021","unstructured":"Torres, E. R. S. et al. Alpha-synuclein pathology, microgliosis, and parvalbumin neuron loss in the amygdala associated with enhanced fear in the Thy1-aSyn model of Parkinson\u2019s disease. Neurobiol. Dis. 158, 105478 (2021).","journal-title":"Neurobiol. Dis."},{"key":"1200_CR38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/(SICI)1096-9861(20000529)421:2<215::AID-CNE7>3.0.CO;2-U","volume":"421","author":"JZ Barlow","year":"2000","unstructured":"Barlow, J. Z. & Huntley, G. W. Developmentally regulated expression of Thy-1 in structures of the mouse sensory-motor system. J. Comp. Neurol. 421, 215\u2013233 (2000).","journal-title":"J. Comp. Neurol."},{"key":"1200_CR39","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s13311-012-0104-2","volume":"9","author":"MF Chesselet","year":"2012","unstructured":"Chesselet, M. F. et al. A progressive mouse model of Parkinson\u2019s disease: the Thy1-aSyn (\u201cLine 61\u201d) mice. Neurotherapeutics 9, 297\u2013314 (2012).","journal-title":"Neurotherapeutics"},{"key":"1200_CR40","doi-asserted-by":"publisher","unstructured":"Castro, B. & Kuang, S. Evaluation of muscle performance in mice by treadmill exhaustion test and whole-limb grip strength assay. Bio Protoc. 7, https:\/\/doi.org\/10.21769\/BioProtoc.2237 (2017).","DOI":"10.21769\/BioProtoc.2237"},{"key":"1200_CR41","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neulet.2012.09.021","volume":"529","author":"J Chen","year":"2012","unstructured":"Chen, J., Qin, J., Su, Q., Liu, Z. & Yang, J. Treadmill rehabilitation treatment enhanced BDNF-TrkB but not NGF-TrkA signaling in a mouse intracerebral hemorrhage model. Neurosci. Lett. 529, 28\u201332 (2012).","journal-title":"Neurosci. Lett."},{"key":"1200_CR42","first-page":"552","volume":"71","author":"WM Fowler Jr.","year":"1990","unstructured":"Fowler, W. M. Jr., Abresch, R. T., Larson, D. B., Sharman, R. B. & Entrikin, R. K. High-repetitive submaximal treadmill exercise training: effect on normal and dystrophic mice. Arch. Phys. Med Rehabil. 71, 552\u2013557 (1990).","journal-title":"Arch. Phys. Med Rehabil."},{"key":"1200_CR43","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/gerona\/glx120","volume":"73","author":"KL Seldeen","year":"2018","unstructured":"Seldeen, K. L. et al. High intensity interval training improves physical performance and frailty in aged mice. J. Gerontol. A Biol. Sci. Med Sci. 73, 429\u2013437 (2018).","journal-title":"J. Gerontol. A Biol. Sci. Med Sci."},{"key":"1200_CR44","doi-asserted-by":"publisher","DOI":"10.3791\/59138","author":"KL Seldeen","year":"2019","unstructured":"Seldeen, K. L. et al. Short session high intensity interval training and treadmill assessment in aged mice. J. Vis. Exp. https:\/\/doi.org\/10.3791\/59138 (2019).","journal-title":"J. Vis. Exp."},{"key":"1200_CR45","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.neulet.2004.09.060","volume":"372","author":"YJ Sim","year":"2004","unstructured":"Sim, Y. J., Kim, S. S., Kim, J. Y., Shin, M. S. & Kim, C. J. Treadmill exercise improves short-term memory by suppressing ischemia-induced apoptosis of neuronal cells in gerbils. Neurosci. Lett. 372, 256\u2013261 (2004).","journal-title":"Neurosci. Lett."},{"key":"1200_CR46","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.lfs.2012.10.003","volume":"91","author":"YH Sung","year":"2012","unstructured":"Sung, Y. H. et al. Treadmill exercise ameliorates dopaminergic neuronal loss through suppressing microglial activation in Parkinson\u2019s disease mice. Life Sci. 91, 1309\u20131316 (2012).","journal-title":"Life Sci."},{"key":"1200_CR47","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s00702-022-02514-4","volume":"129","author":"H Ga\u00dfner","year":"2022","unstructured":"Ga\u00dfner, H. et al. Treadmill training and physiotherapy similarly improve dual task gait performance: a randomized-controlled trial in Parkinson\u2019s disease. J. Neural Transm. (Vienna) 129, 1189\u20131200 (2022).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"1200_CR48","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3233\/NRE-193013","volume":"46","author":"LT Aguiar","year":"2020","unstructured":"Aguiar, L. T. et al. Effects of aerobic training on physical activity in people with stroke: A randomized controlled trial. NeuroRehabilitation 46, 391\u2013401 (2020).","journal-title":"NeuroRehabilitation"},{"key":"1200_CR49","doi-asserted-by":"publisher","unstructured":"Hansen, E. S. H. et al. Effect of aerobic exercise training on asthma in adults: a systematic review and meta-analysis. Eur. Respir. J. 56, https:\/\/doi.org\/10.1183\/13993003.00146-2020 (2020).","DOI":"10.1183\/13993003.00146-2020"},{"key":"1200_CR50","doi-asserted-by":"crossref","unstructured":"Mehrholz, J. et al. Treadmill training for patients with Parkinson\u2019s disease. Cochrane Database Syst. Rev. Cd007830, (2015).","DOI":"10.1002\/14651858.CD007830.pub3"},{"key":"1200_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.irn.2019.06.001","volume":"147","author":"MKY Mak","year":"2019","unstructured":"Mak, M. K. Y. & Wong-Yu, I. S. K. Exercise for Parkinson\u2019s disease. Int Rev. Neurobiol. 147, 1\u201344 (2019).","journal-title":"Int Rev. Neurobiol."},{"key":"1200_CR52","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.gaitpost.2022.02.017","volume":"93","author":"MC Donlin","year":"2022","unstructured":"Donlin, M. C., Pariser, K. M., Downer, K. E. & Higginson, J. S. Adaptive treadmill walking encourages persistent propulsion. Gait Posture 93, 246\u2013251 (2022).","journal-title":"Gait Posture"},{"key":"1200_CR53","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.expneurol.2012.11.020","volume":"240","author":"DG Walker","year":"2013","unstructured":"Walker, D. G. et al. Changes in properties of serine 129 phosphorylated alpha-synuclein with progression of Lewy-type histopathology in human brains. Exp. Neurol. 240, 190\u2013204 (2013).","journal-title":"Exp. Neurol."},{"key":"1200_CR54","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara, H. et al. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat. cell Biol. 4, 160\u2013164 (2002).","journal-title":"Nat. cell Biol."},{"key":"1200_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106773","volume":"205","author":"AS Hartke","year":"2025","unstructured":"Hartke, A. S. et al. Alpha-synuclein pathology enhances peripheral and CNS immune responses to bacterial endotoxins. Neurobiol. Dis. 205, 106773 (2025).","journal-title":"Neurobiol. Dis."},{"key":"1200_CR56","doi-asserted-by":"publisher","first-page":"9592","DOI":"10.1523\/JNEUROSCI.5610-12.2013","volume":"33","author":"AS Harms","year":"2013","unstructured":"Harms, A. S. et al. MHCII is required for alpha-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. J. Neurosci. 33, 9592\u20139600 (2013).","journal-title":"J. Neurosci."},{"key":"1200_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105028","volume":"144","author":"TI Kam","year":"2020","unstructured":"Kam, T. I., Hinkle, J. T., Dawson, T. M. & Dawson, V. L. Microglia and astrocyte dysfunction in parkinson\u2019s disease. Neurobiol. Dis. 144, 105028 (2020).","journal-title":"Neurobiol. Dis."},{"key":"1200_CR58","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41531-023-00547-4","volume":"9","author":"TT Lai","year":"2023","unstructured":"Lai, T. T. et al. Anxiety in synucleinopathies: neuronal circuitry, underlying pathomechanisms and current therapeutic strategies. NPJ Parkinsons Dis. 9, 97 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"1200_CR59","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1093\/brain\/awae177","volume":"147","author":"C Roodveldt","year":"2024","unstructured":"Roodveldt, C. et al. The immune system in Parkinson\u2019s disease: what we know so far. Brain 147, 3306\u20133324 (2024).","journal-title":"Brain"},{"key":"1200_CR60","doi-asserted-by":"publisher","first-page":"S149","DOI":"10.3233\/JPD-223245","volume":"12","author":"MH Terkelsen","year":"2022","unstructured":"Terkelsen, M. H. et al. Neuroinflammation and Immune Changes in Prodromal Parkinson\u2019s Disease and Other Synucleinopathies. J. Parkinsons Dis. 12, S149\u2013S163 (2022).","journal-title":"J. Parkinsons Dis."},{"key":"1200_CR61","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/mds.26728","volume":"31","author":"SC LaHue","year":"2016","unstructured":"LaHue, S. C., Comella, C. L. & Tanner, C. M. The best medicine? The influence of physical activity and inactivity on Parkinson\u2019s disease. Mov. Disord. 31, 1444\u20131454 (2016).","journal-title":"Mov. Disord."},{"key":"1200_CR62","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3988\/jcn.2015.11.3.212","volume":"11","author":"T Paillard","year":"2015","unstructured":"Paillard, T., Rolland, Y. & de Souto Barreto, P. Protective effects of physical exercise in Alzheimer\u2019s disease and Parkinson\u2019s disease: a narrative review. J. Clin. Neurol. 11, 212\u2013219 (2015).","journal-title":"J. Clin. Neurol."},{"key":"1200_CR63","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0306-4522(03)00096-4","volume":"119","author":"JL Tillerson","year":"2003","unstructured":"Tillerson, J. L., Caudle, W. M., Rever\u00f3n, M. E. & Miller, G. W. Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson\u2019s disease. Neuroscience 119, 899\u2013911 (2003).","journal-title":"Neuroscience"},{"key":"1200_CR64","doi-asserted-by":"publisher","first-page":"6790","DOI":"10.1523\/JNEUROSCI.22-15-06790.2002","volume":"22","author":"JL Tillerson","year":"2002","unstructured":"Tillerson, J. L. et al. Forced nonuse in unilateral parkinsonian rats exacerbates injury. J. Neurosci. 22, 6790\u20136799 (2002).","journal-title":"J. Neurosci."},{"key":"1200_CR65","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","volume":"23","author":"C Challis","year":"2020","unstructured":"Challis, C. et al. Gut-seeded alpha-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice. Nat. Neurosci. 23, 327\u2013336 (2020).","journal-title":"Nat. Neurosci."},{"key":"1200_CR66","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson, T. R. et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167, 1469\u20131480.e1412 (2016).","journal-title":"Cell"},{"key":"1200_CR67","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","volume":"7","author":"S Romano","year":"2021","unstructured":"Romano, S. et al. Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis. 7, 27 (2021).","journal-title":"NPJ Parkinsons Dis."},{"key":"1200_CR68","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1002\/mds.29128","volume":"37","author":"A Xie","year":"2022","unstructured":"Xie, A. et al. Bacterial Butyrate in Parkinson\u2019s disease is linked to epigenetic changes and depressive symptoms. Mov. Disord. 37, 1644\u20131653 (2022).","journal-title":"Mov. Disord."},{"key":"1200_CR69","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41586-022-05525-z","volume":"612","author":"L Dohnalova","year":"2022","unstructured":"Dohnalova, L. et al. A microbiome-dependent gut-brain pathway regulates motivation for exercise. Nature 612, 739\u2013747 (2022).","journal-title":"Nature"},{"key":"1200_CR70","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ctim.2015.01.015","volume":"23","author":"S Rios Romenets","year":"2015","unstructured":"Rios Romenets, S., Anang, J., Fereshtehnejad, S. M., Pelletier, A. & Postuma, R. Tango for treatment of motor and non-motor manifestations in Parkinson\u2019s disease: a randomized control study. Complement Ther. Med 23, 175\u2013184 (2015).","journal-title":"Complement Ther. Med"},{"key":"1200_CR71","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1089\/acm.2018.0413","volume":"25","author":"P Solla","year":"2019","unstructured":"Solla, P. et al. Sardinian folk dance for individuals with Parkinson\u2019s disease: a randomized controlled pilot trial. J. Alter. Complement. Med 25, 305\u2013316 (2019).","journal-title":"J. Alter. Complement. Med"},{"key":"1200_CR72","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1471-2318-13-54","volume":"13","author":"D Volpe","year":"2013","unstructured":"Volpe, D., Signorini, M., Marchetto, A., Lynch, T. & Morris, M. E. A comparison of Irish set dancing and exercises for people with Parkinson\u2019s disease: a phase II feasibility study. BMC Geriatr. 13, 54 (2013).","journal-title":"BMC Geriatr."},{"key":"1200_CR73","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neulet.2017.08.076","volume":"659","author":"A Flach","year":"2017","unstructured":"Flach, A. et al. Endurance exercise improves function in individuals with Parkinson\u2019s disease: A meta-analysis. Neurosci. Lett. 659, 115\u2013119 (2017).","journal-title":"Neurosci. Lett."},{"key":"1200_CR74","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/s41591-019-0485-4","volume":"25","author":"J Scheiman","year":"2019","unstructured":"Scheiman, J. et al. Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism. Nat. Med. 25, 1104\u20131109 (2019).","journal-title":"Nat. Med."},{"key":"1200_CR75","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40035-022-00280-7","volume":"11","author":"G Li","year":"2022","unstructured":"Li, G. et al. Mechanisms of motor symptom improvement by long-term Tai Chi training in Parkinson\u2019s disease patients. Transl. Neurodegener. 11, 6 (2022).","journal-title":"Transl. Neurodegener."},{"key":"1200_CR76","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/PHM.0000000000000858","volume":"97","author":"RP Hubble","year":"2018","unstructured":"Hubble, R. P., Naughton, G., Silburn, P. A. & Cole, M. H. Trunk exercises improve gait symmetry in Parkinson disease: a blind Phase II randomized Controlled Trial. Am. J. Phys. Med Rehabil. 97, 151\u2013159 (2018).","journal-title":"Am. J. Phys. Med Rehabil."},{"key":"1200_CR77","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.gaitpost.2017.04.006","volume":"55","author":"EM Atterbury","year":"2017","unstructured":"Atterbury, E. M. & Welman, K. E. Balance training in individuals with Parkinson\u2019s disease: Therapist-supervised vs. home-based exercise programme. Gait Posture 55, 138\u2013144 (2017).","journal-title":"Gait Posture"},{"key":"1200_CR78","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.apmr.2015.10.095","volume":"97","author":"M Ni","year":"2016","unstructured":"Ni, M. et al. Comparative effect of power training and high-speed yoga on motor function in older patients with Parkinson disease. Arch. Phys. Med. Rehabil. 97, 345\u2013354.e315 (2016).","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"1200_CR79","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jphys.2019.02.003","volume":"65","author":"L Cugusi","year":"2019","unstructured":"Cugusi, L. et al. Aquatic exercise improves motor impairments in people with Parkinson\u2019s disease, with similar or greater benefits than land-based exercise: a systematic review. J. Physiother. 65, 65\u201374 (2019).","journal-title":"J. Physiother."},{"key":"1200_CR80","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s13311-017-0544-9","volume":"14","author":"F Richter","year":"2017","unstructured":"Richter, F. et al. A molecular Tweezer Ameliorates motor deficits in mice overexpressing alpha-Synuclein. Neurotherapeutics 14, 1107\u20131119 (2017).","journal-title":"Neurotherapeutics"},{"key":"1200_CR81","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bbr.2016.02.017","volume":"304","author":"J Gerstenberger","year":"2016","unstructured":"Gerstenberger, J., Bauer, A., Helmschrodt, C., Richter, A. & Richter, F. The novel adaptive rotating beam test unmasks sensorimotor impairments in a transgenic mouse model of Parkinson\u2019s disease. Behav. Brain Res. 304, 102\u2013110 (2016).","journal-title":"Behav. Brain Res."},{"key":"1200_CR82","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/jnr.21159","volume":"85","author":"F Richter","year":"2007","unstructured":"Richter, F., Hamann, M. & Richter, A. Chronic rotenone treatment induces behavioral effects but no pathological signs of parkinsonism in mice. J. Neurosci. Res. 85, 681\u2013691 (2007).","journal-title":"J. Neurosci. Res."},{"key":"1200_CR83","doi-asserted-by":"publisher","first-page":"4516","DOI":"10.1073\/pnas.1000080107","volume":"108","author":"JG Caporaso","year":"2011","unstructured":"Caporaso, J. G. et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc. Natl Acad. Sci. USA 108, 4516\u20134522 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1200_CR84","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/nmeth.2604","volume":"10","author":"RC Edgar","year":"2013","unstructured":"Edgar, R. C. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat. Methods 10, 996\u2013998 (2013).","journal-title":"Nat. Methods"},{"key":"1200_CR85","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590\u2013D596 (2013).","journal-title":"Nucleic Acids Res."},{"key":"1200_CR86","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.1128\/AEM.00062-07","volume":"73","author":"Q Wang","year":"2007","unstructured":"Wang, Q., Garrity, G. M., Tiedje, J. M. & Cole, J. R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol 73, 5261\u20135267 (2007).","journal-title":"Appl. Environ. Microbiol"},{"key":"1200_CR87","doi-asserted-by":"publisher","first-page":"e61217","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie, P. J. & Holmes, S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PloS One 8, e61217 (2013).","journal-title":"PloS One"},{"key":"1200_CR88","unstructured":"Pipe-Friendly Framework for Basic Statistical Tests [R Package Rstatix Version 0.7.0] (2021)."},{"key":"1200_CR89","unstructured":"Oksanen, J. et al. Vegan: community ecology package. R package version 2.5\u20137. https:\/\/cran.r-project.org\/package=vegan (2020)."},{"key":"1200_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"1200_CR91","doi-asserted-by":"crossref","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Royal Stat. Soc. B (Methodol.), 289\u2013300, (1995).","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01200-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01200-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01200-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:09:04Z","timestamp":1764180544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01200-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,23]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1200"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01200-y","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,23]]},"assertion":[{"value":"14 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"335"}}